Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01925469 · ClinicalTrials.gov registry record · Phase 4
Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram
A Phase 4 study of Analgesia and Pain Relief, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01925469 is a Phase 4 study of Analgesia and Pain Relief that has completed, run by University of Pennsylvania. The registered enrollment target is 30 participants, below the 91-participant average among 19 other Analgesia trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01925469, a Phase 4 study of Analgesia and Pain Relief, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the utility of benzocaine spray versus a placebo spray in alleviating pain during and after hysterosalpingogram (HSG).
Conditions Studied
Interventions
- DRUG Benzocaine
- DRUG Saline spray
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01925469
The ClinicalTrials.gov registry entry for NCT01925469 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 19 other Analgesia trials with a reported enrollment target (67% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Analgesia appearing as the primary indexed condition, and to 2 interventions - of which Benzocaine is the first listed.
NCT01925469 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01925469 about?
NCT01925469 is a clinical study titled "Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram". The objective of this study is to assess the utility of benzocaine spray versus a placebo spray in alleviating pain during and after hysterosalpingogram (HSG).
What is the current status of trial NCT01925469?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2011-12. Estimated completion is 2012-04.
What conditions does trial NCT01925469 study?
This clinical trial studies the following conditions: Analgesia, Pain Relief.
What interventions are being tested in trial NCT01925469?
The interventions under investigation include: Benzocaine (DRUG), Saline spray (DRUG).
Who is sponsoring clinical trial NCT01925469?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01925469 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Analgesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO
RECRUITING · Phase 4
-
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
RECRUITING · Phase 4
-
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
TAP-patients With Robotic Assisted Lap Prostatectomy
COMPLETED · Phase 4
-
Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.